Factor V Leiden and sepsis: Proof positive or phenomenology?*

This publication has 15 references indexed in Scilit:

• Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice*
  Critical Care Medicine, 2006
• Influence of the Factor V Leiden Mutation on Infectious Disease Susceptibility and Outcome: A Population‐Based Study
  The Journal of Infectious Diseases, 2005
• The interactions between inflammation and coagulation
  British Journal of Haematology, 2005
• Factor V Leiden polymorphism modifies sepsis outcome: Evidence from animal studies
  Critical Care Medicine, 2004
• Effect of factor V Leiden polymorphism in severe sepsis and on treatment with recombinant human activated protein C
  Critical Care Medicine, 2004
• Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia
  Blood, 2003
• Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation
  Critical Care Medicine, 2001
• Different Sensitivities of Various Thromboplastins to Two Blood Collection Systems for Monitoring Oral Anticoagulant Therapy
  Thrombosis and Haemostasis, 1999
• A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.
  Journal of Clinical Investigation, 1998
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994